Raymond James Financial’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Sell
434,419
-64,319
-13% -$3.95M 0.01% 1491
2026
Q1
$32.5M Buy
498,738
+56,562
+13% +$4.14M 0.01% 1135
2025
Q4
$35.6M Sell
442,176
-60,159
-12% -$4.84M 0.01% 1041
2025
Q3
$41.2M Sell
502,335
-14,856
-3% -$1.29M 0.01% 917
2025
Q2
$47.2M Buy
517,191
+30,037
+6% +$2.68M 0.02% 792
2025
Q1
$44.6M Sell
487,154
-35,446
-7% -$3.09M 0.02% 783
2024
Q4
$44.5M Buy
+522,600
New +$45.9M 0.02% 782

Other funds holding DOX

Raymond James Financial's DOX Position: Q2 2026 in Review

Raymond James Financial reduced its Amdocs (DOX) stake by 13% in Q2 2026, selling an estimated $3.95M and leaving 434,419 shares worth $22M. The position accounts for 0.01% of the portfolio, ranked #1491.

Raymond James Financial first reported a position in DOX in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.2M in Q2 2025. 448 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Raymond James Financial held 434,419 shares of Amdocs worth $22M as of Q2 2026.
  • Raymond James Financial sold 64,319 Amdocs shares in Q2 2026, an estimated $3.95M.
  • Amdocs made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1491 holding.
  • Raymond James Financial first reported a position in Amdocs in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Amdocs position peaked at $47.2M in Q2 2025.
  • 448 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.